Search results for "Germany"

showing 10 items of 1172 documents

Disclosure of duplicative studies: damned if you don't

2012

Duplicative publication requires duplicative editorializing. There are many forms of lesser redundancy such as unacknowledged secondary analyses of randomized clinical trials, fragmentation of studies with concurrent submission to various journals, and serial updating of observational studies. These practices result in publication bias. We have revised our instructions to authors to include disclosure of similar articles that are published, in press, or submitted to other journals to the editors upon submission.

PublishingClinical Trials as TopicActuarial scienceComputer scienceWritingManuscripts Medical as TopicObstetrics and GynecologyDisclosurePublication biaslaw.inventionReproductive MedicineRandomized controlled triallawGermanyRedundancy (engineering)Observational studyGuideline AdherencePeriodicals as TopicEditorial PoliciesFertility and Sterility
researchProduct

Outcome after mitral valve operations with depressed left ventricular function.

2012

We retrospectively investigated 42 patients (27 men, 15 women; mean age, 67 years) with severe mitral valve incompetence and endstage cardiomyopathy (ejection fraction <30%) who were operated on between January 2002 and March 2009. Of these, 14 were in New York Heart Association class IV, and 27 were in class III. The etiology was ischemic in 18 patients and idiopathic dilated in 24. Mitral valve repair was performed in 25 patients, and 17 had mitral valve replacement. The mean logistic EuroSCORE was 33.41. The mean follow-up was 44.52 months. There were no perioperative deaths. Three patients died within 30 days postoperatively. Thirty-day mortality was lower than predicted by EuroSCOR…

Pulmonary and Respiratory MedicineAdultMaleReoperationmedicine.medical_specialtyTime Factorsmedicine.medical_treatmentCardiomyopathyKaplan-Meier EstimateRisk AssessmentSeverity of Illness IndexVentricular Function LeftVentricular Dysfunction LeftRisk FactorsInternal medicineMitral valveGermanymedicineHumansCardiac Surgical ProceduresSurvival rateAgedProportional Hazards ModelsRetrospective StudiesAged 80 and overHeart Valve Prosthesis ImplantationMitral valve repairEjection fractionbusiness.industryMitral valve replacementMitral Valve InsufficiencyEuroSCOREStroke VolumeGeneral MedicinePerioperativeMiddle Agedmedicine.diseaseSurgerymedicine.anatomical_structureLogistic ModelsTreatment OutcomeMultivariate AnalysisCardiologyMitral ValveSurgeryFemaleCardiology and Cardiovascular MedicinebusinessCardiomyopathiesAsian cardiovascularthoracic annals
researchProduct

Feasibility of functional magnetic resonance lung imaging in Australia with long distance transport of hyperpolarized helium from Germany.

2008

MRI of the lung using hyperpolarized helium as an inhaled contrast agent has important research applications and clinical potential. Owing to the limited availability of hyperpolarized helium, this type of imaging has not been performed in the human lung outside of North America or Europe. The objective of this study was to test the feasibility of imaging human lungs in Australia using hyperpolarized helium gas imported from Germany.A Bruker 2-Tesla whole-body magnetic resonance scanner located in Brisbane, Australia was adapted with a helium-3 radiofrequency transceiver coil. Helium-3 was hyperpolarized to 72% in Mainz, Germany and airfreighted to Brisbane. The time taken for the journey w…

Pulmonary and Respiratory MedicineAdultMalegenetic structuresContrast MediaHeliumHuman lungIsotopesGermanyLung imagingAdministration InhalationmedicineHumansmedicine.diagnostic_testbusiness.industryAustraliaMagnetic resonance imagingrespiratory systemDiagnostic ServicesMagnetic Resonance Imagingrespiratory tract diseasesHyperpolarized heliumImportant researchmedicine.anatomical_structureFeasibility StudiesNuclear medicinebusinessAviationRespirology (Carlton, Vic.)
researchProduct

Efficacy of a fixed combination of ciclesonide and formoterol: the EXCITED-study.

2011

SummaryRecommended treatment for moderate to severe asthma is the combination of an inhaled corticosteroid and a long-acting beta2-agonist. The present study was designed to evaluate the efficacy of a newly developed fixed combination of ciclesonide and formoterol in comparison to the marketed fixed combination of fluticasone and salmeterol in patients with moderate asthma.This was a phase II, multi-centre, randomized, parallel-group, double-blind, double-dummy study. After a 2-week run-in period, 160 patients with moderate asthma were randomized to a 6-week treatment with ciclesonide/formoterol 320/9 μg bid (CIC/F) or fluticasone propionate/salmeterol 250/50 μg bid (FP/S), both delivered a…

Pulmonary and Respiratory MedicineAdultMalemedicine.medical_specialtyAdolescentUrologyCiclesonideCiclesonideFluticasone propionatechemistry.chemical_compoundYoung AdultDouble-Blind Methodimmune system diseasesPregnenedionesForced Expiratory VolumeFormoterol FumarateGermanyAdministration InhalationmedicineHumansFixed combinationAlbuterolFormoterolAnti-Asthmatic AgentsChildGlucocorticoidsFluticasoneAgedFluticasone-Salmeterol Drug Combinationbusiness.industryrespiratory systemMiddle AgedAsthmaFluticasone-Salmeterol Drug Combinationrespiratory tract diseasesBronchodilator AgentsAndrostadienesDrug CombinationsTreatment OutcomeTolerabilitychemistryEthanolaminesAustriaFormoterol FumarateFemaleSalmeterolFormoterolbusinessmedicine.drugRespiratory medicine
researchProduct

Effectiveness of omalizumab in patients 50 years and older with severe persistent allergic asthma.

2010

Omalizumab is approved for the treatment of severe allergic asthma.To compare the efficacy of omalizumab therapy in patients 50 years or older with patients younger than 50 years.Between November 2005 and November 2007 a total of 174 asthma patients 50 years or older (40.7% male, 51.1% taking oral corticosteroids, and mean [SD] serum IgE level of 315 [353] U/L) and 297 asthma patients younger than 50 years (40.0% male, 50.5% taking oral corticosteroids, and mean [SD] serum IgE level of 363 [431] U/L) who met the European Union criteria for add-on therapy with anti-IgE were treated prospectively with omalizumab for 4 months as part of 2 postmarketing surveillance trials.Compared with the pre…

Pulmonary and Respiratory MedicineAdultMalemedicine.medical_specialtyAllergyPediatricsAdolescentImmunologyPostmarketing surveillanceOmalizumabOmalizumabImmunoglobulin EAntibodies Monoclonal HumanizedGermanymedicineProduct Surveillance PostmarketingImmunology and Allergymedia_common.cataloged_instanceHumansAnti-Asthmatic AgentsEuropean unionAdverse effectChildmedia_commonAsthmaAgedbiologybusiness.industryAge FactorsAntibodies MonoclonalImmunoglobulin EMiddle Agedmedicine.diseaseAsthmaSurgeryDiscontinuationAntibodies Anti-IdiotypicRespiratory Function Testsbiology.proteinDisease ProgressionFemalebusinessmedicine.drugFollow-Up StudiesAnnals of allergy, asthmaimmunology : official publication of the American College of Allergy, Asthma,Immunology
researchProduct

Social isolation and depression predict 12-month outcomes in the "waiting for a new heart study".

2009

Identification of modifiable psychosocial characteristics related to survival of heart transplant (HTx) candidates is needed to prevent clinical deterioration and improve prognosis.A multi-site, prospective study was conducted with 318 HTx candidates (18% female, 82% male; 53 +/- 11 years of age) newly listed at 17 hospitals in Germany and Austria. Baseline demographic and psychosocial characteristics were assessed by questionnaires. Indicators of disease severity (Heart Failure Survival Score, creatinine, cardiac index) and 12-month outcomes (death, high-urgency HTx, elective HTx, de-listing due to deterioration or improvement) were provided by Eurotransplant.By 12 months, 33 patients died…

Pulmonary and Respiratory MedicineAdultMalemedicine.medical_specialtyHeart DiseasesWaiting Listsmedicine.medical_treatmentCardiac indexSeverity of Illness Indexchemistry.chemical_compoundRisk FactorsInternal medicineGermanyOutcome Assessment Health CaremedicineHumansPsychologyProspective StudiesSocial isolationProspective cohort studyDepression (differential diagnoses)AgedHeart transplantationTransplantationCreatininebusiness.industryDepressionMiddle Agedmedicine.diseasePrognosisSurgerychemistrySocial IsolationHeart failureAustriaHeart TransplantationSurgeryFemalemedicine.symptomCardiology and Cardiovascular MedicinebusinessPsychosocialThe Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
researchProduct

Inhaled isoflurane via the anaesthetic conserving device versus propofol for sedation of invasively ventilated patients in intensive care units in Ge…

2021

Summary Background Previous studies indicate that isoflurane could be useful for the sedation of patients in the intensive care unit (ICU), but prospective studies evaluating isoflurane's efficacy have been small. The aim of this study was to test whether the sedation with isoflurane was non-inferior to sedation with propofol. Methods This phase 3, randomised, controlled, open-label non-inferiority trial evaluated the efficacy and safety of up to 54 h of isoflurane compared with propofol in adults (aged ≥18 years) who were invasively ventilated in ICUs in Germany (21 sites) and Slovenia (three sites). Patients were randomly assigned (1:1) to isoflurane inhalation via the Sedaconda anaesthet…

Pulmonary and Respiratory MedicineAdultSedationPopulationSlovenialaw.inventionlawIntensive careGermanyClinical endpointMedicineHumansHypnotics and SedativesProspective StudieseducationProspective cohort studyPropofolAnestheticseducation.field_of_studyIsofluranebusiness.industryIntensive care unitRespiration ArtificialIntensive Care UnitsIsofluraneAnesthesiamedicine.symptombusinessPropofolmedicine.drugThe Lancet. Respiratory medicine
researchProduct

Value of echocardiography in patient follow-up after surgically corrected type A aortic dissection.

2001

Background To identify patients (pts) at risk of late complications, follow-up after surgery for type A aortic dissection is essential. We assessed the value of echocardiography to monitor patients after surgery for type A aortic dissection. Methods 80 out of 108 pts operated between 1989 and 1999 for type A aortic dissection survived surgery. 62 pts with at least one TEE, CT or MRI examinations during follow-up were included in this study. All pts had transthoracic echocardiography (TTE), 53 transesophageal echocardiography (TEE), 51 had CT, and 39 had MRI. Results At the first follow-up, 12 of 48 pts with aortic valve sparing surgery presented with aortic insufficiency >I degrees detected…

Pulmonary and Respiratory MedicineAortic archAortic valveAdultMaleReoperationmedicine.medical_specialtyTime FactorsAortic Valve InsufficiencySeverity of Illness IndexDiagnosis DifferentialAortic aneurysmAneurysmmedicine.arteryGermanymedicineHumansAgedAortic dissectionAged 80 and overPostoperative Caremedicine.diagnostic_testbusiness.industryMagnetic resonance imagingStroke VolumeStroke volumeMiddle Agedmedicine.diseaseImage EnhancementMagnetic Resonance ImagingSurvival AnalysisAortic AneurysmAortic Dissectionmedicine.anatomical_structureEchocardiographyAortic Valvecardiovascular systemDisease ProgressionSurgeryFemaleRadiologyDifferential diagnosisCardiology and Cardiovascular MedicinebusinessTomography X-Ray Computedhuman activitiesFollow-Up StudiesThe Thoracic and cardiovascular surgeon
researchProduct

Intraoperative neuroprotective drugs without beneficial effects? Results of the German Registry for Acute Aortic Dissection Type A (GERAADA).

2013

OBJECTIVES: Cerebral protection during acute aortic dissection Type A (AADA) surgery may be affected by perfusion strategies and ischaemic protective drugs. METHODS: We analysed the impact of intraoperative barbiturate, steroid and mannitol use and adjunctive cerebral perfusion (CP), on 30-day mortality and new postoperative mortality-corrected permanent neurological dysfunction (PNDmc) in the German Registry for Acute Aortic Dissection Type A. RESULTS: Two thousand one hundred and thirty-seven AADA patients were registered over a 4-year period. The overall 30-day mortality was 16.9%, and the overall rate of PNDmc was 10.0%. A total of 48% of patients received no neuroprotective drugs (cont…

Pulmonary and Respiratory MedicineAortic archMalemedicine.drug_classOperative TimePostoperative ComplicationsRisk Factorsmedicine.arteryGermanymedicineHumansMannitolCerebral perfusion pressureCardiac Surgical ProceduresMortalityAgedAortic dissectionChi-Square DistributionIntraoperative Carebusiness.industryMortality rateGeneral MedicineOdds ratioMiddle Agedmedicine.diseaseAortic AneurysmAortic DissectionNeuroprotective AgentsBarbiturateAnesthesiaBarbituratesSurgeryFemaleSteroidsMannitolCardiology and Cardiovascular MedicinebusinessPerfusionmedicine.drugEuropean journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
researchProduct

Lung cancer survival in Germany: A population-based analysis of 132,612 lung cancer patients.

2014

Lung cancer is the most common cancer-related death worldwide. In Germany it accounts for 25% of cancer deaths in men, and 14% in women. The aim of this study is to provide an overview of 5-year relative survival by sex, age, histology, and tumour stage in Germany representing a population of 26.7 million people.The study is based on a pooled German dataset including data from 12 population-based cancer registries covering around one third of the German population. A total of 132,612 patients diagnosed with lung cancer from 2002 to 2010 were included in the analysis. Survival estimates for the time period 2007-2010 were calculated using period analysis. Differences in survival between sexes…

Pulmonary and Respiratory MedicineGerontologyAdultMaleCancer ResearchLung NeoplasmsAdolescentPopulationAge adjustmentsymbols.namesakeYoung AdultSex FactorsGermanymedicineHumansPoisson regressionRegistrieseducationLung cancerAgedNeoplasm StagingAged 80 and overeducation.field_of_studyRelative survivalbusiness.industryAbsolute risk reductionAge FactorsCancerMiddle Agedmedicine.diseaseCancer registryOncologyPopulation SurveillancesymbolsFemalebusinessDemographyLung cancer (Amsterdam, Netherlands)
researchProduct